Bio Medica Laboratories Limited (NSE:BMLL)
India · Delayed Price · Currency is INR 145.35
-6.60 (-4.34%)
At close: Nov 6, 2026
Bio Medica Laboratories Revenue
In the fiscal year ending March 31, 2026, Bio Medica Laboratories had annual revenue of 430.90M INR with 12.45% growth. That makes Bio Medica Laboratories the 40,286th largest company in the world by revenue and 3,886th in India.
Revenue
430.90M
Revenue Growth
+12.45%
P/S Ratio
4.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.83B
Revenue by Geography
- India 418.97M 97.2%
- Unallocated 7.99M 1.9%
- Export 3.93M 0.9%
Fiscal year ended Mar 31, 2026 See the full Bio Medica Laboratories breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 430.90M | 47.70M | 12.45% |
| Mar 31, 2025 | 383.20M | 230.70M | 151.29% |
| Mar 31, 2024 | 152.49M | -9.79M | -6.03% |
| Mar 31, 2023 | 162.28M | -49.97M | -23.54% |
| Mar 31, 2022 | 212.25M | 83.00M | 64.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 8.38B |
| Medico Remedies | 2.38B |
| Sat Kartar Life | 2.24B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| Accretion Pharmaceuticals | 1.01B |